Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04065165
Brief Title: Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome (TELEFIRST)

First Submitted : August 14, 2019
First Submitted that Met QC Criteria : August 21, 2019
First Posted : August 22, 2019

Last Update Submitted that Met QC Criteria : August 21, 2019
Last Update Posted : August 22, 2019